Provention Bio, Inc. PRVB
Set alert
24.98 0.00 0.00%
At close · Apr 26
24.98 Day range 25.00
52-week range unavailable
- Open
- 24.99
- Prev close
- 24.98
- Mkt cap
- 2.38B
- Vol
- 9.12M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 24.98
- High
- 25.00
- Forward P/E
- -192.15
- Beta
- 2.46
- Short ratio
- 1.53
- Inst. own
- 53.26%
- Dividend
- 0.00
- Ex-div date
- Earnings
- May 4, 2023
- 50-d avg
- 19.10
- 200-d avg
- 10.15
- 1y target
- 23.50
Financial health
Altman Z-Score
8.72 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -7.0×
FY 2016 5y median -7.0× FY 2022
P/S 61.3×
FY 2016 5y median 0.0× FY 2022
P/B 6.5×
FY 2016 5y median -1.2× FY 2022
P/FCF -10.4×
FY 2016 5y median -10.4× FY 2022
EV/EBITDA -6.2×
FY 2016 5y median -6.2× FY 2022
EV/Sales 59.7×
FY 2016 5y median 0.0× FY 2022
FCF Yield -9.6%
FY 2016 5y median -9.6% FY 2022
Profitability
Gross Margin 96.0%
FY 2016 5y median 0.0% FY 2022
Operating Margin -993.9%
FY 2016 5y median 0.0% FY 2022
Net Margin -880.7%
FY 2016 5y median 0.0% FY 2022
ROE -93.2%
FY 2016 5y median 39.2% FY 2022
ROIC -78.3%
FY 2016 5y median -78.3% FY 2022
ROA -47.9%
FY 2016 5y median -47.9% FY 2022
Growth (YoY)
Revenue 824.4%
FY 2016 FY 2022
Operating Income -10.9%
FY 2016 FY 2022
EPS (diluted) 16.0%
FY 2016 FY 2022
Free Cash Flow 20.9%
FY 2016 FY 2022
Financial Health
Current Ratio 1.9×
FY 2016 5y median 7.6× FY 2022
Quick Ratio 1.9×
FY 2016 5y median 7.6× FY 2022
Debt / Equity 0.2×
FY 2016 5y median 0.0× FY 2022
Net Debt / EBITDA 0.2×
FY 2016 5y median 0.9× FY 2022
Interest Coverage -124×
FY 2016 5y median 0.0× FY 2022
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2022
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2022
Annual · latest fiscal year ends 2022-12-31